[go: up one dir, main page]

ZA200806568B - Deuterated catecholamine derivatives and medicaments comprising said compounds - Google Patents

Deuterated catecholamine derivatives and medicaments comprising said compounds

Info

Publication number
ZA200806568B
ZA200806568B ZA200806568A ZA200806568A ZA200806568B ZA 200806568 B ZA200806568 B ZA 200806568B ZA 200806568 A ZA200806568 A ZA 200806568A ZA 200806568 A ZA200806568 A ZA 200806568A ZA 200806568 B ZA200806568 B ZA 200806568B
Authority
ZA
South Africa
Prior art keywords
medicaments
compounds
catecholamine derivatives
deuterated catecholamine
deuterated
Prior art date
Application number
ZA200806568A
Other languages
English (en)
Inventor
Alken Rudolf-Giesbert
Schneider Frank
Original Assignee
Birds Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birds Pharma Gmbh filed Critical Birds Pharma Gmbh
Publication of ZA200806568B publication Critical patent/ZA200806568B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200806568A 2006-02-17 2008-07-28 Deuterated catecholamine derivatives and medicaments comprising said compounds ZA200806568B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006008316 2006-02-17

Publications (1)

Publication Number Publication Date
ZA200806568B true ZA200806568B (en) 2009-07-29

Family

ID=38236462

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806568A ZA200806568B (en) 2006-02-17 2008-07-28 Deuterated catecholamine derivatives and medicaments comprising said compounds

Country Status (24)

Country Link
US (2) US8247603B2 (xx)
EP (2) EP1991522B1 (xx)
JP (1) JP5248331B2 (xx)
KR (1) KR101411422B1 (xx)
CN (1) CN101384545B (xx)
AU (1) AU2007214622B2 (xx)
BR (1) BRPI0708071A8 (xx)
CA (1) CA2642593C (xx)
CY (1) CY1117995T1 (xx)
DK (1) DK1991522T3 (xx)
EA (1) EA017983B1 (xx)
ES (1) ES2587368T3 (xx)
HR (1) HRP20161039T1 (xx)
HU (1) HUE028777T2 (xx)
IL (1) IL193102A (xx)
LT (1) LT1991522T (xx)
ME (1) ME02508B (xx)
PL (1) PL1991522T3 (xx)
PT (1) PT1991522T (xx)
RS (1) RS55142B1 (xx)
SI (1) SI1991522T1 (xx)
UA (1) UA97795C2 (xx)
WO (1) WO2007093450A2 (xx)
ZA (1) ZA200806568B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
HUE037974T2 (hu) 2008-06-06 2018-09-28 Pharma Two B Ltd Gyógyászati kompozíció Parkinson-kór kezelésére
BRPI0916769A2 (pt) 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
HK1212232A1 (en) 2012-09-18 2016-06-10 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
US9763904B2 (en) 2013-02-05 2017-09-19 Teva Pharmaceuticals International Gmbh Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
US9567289B2 (en) * 2013-02-05 2017-02-14 Ratiopharm Gmbh Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
WO2014174425A2 (en) * 2013-04-24 2014-10-30 Mahesh Kandula Compositions and methods for the treatment of orthostasis and neurological diseases
HK1221713A1 (zh) 2013-07-08 2017-06-09 Auspex Pharmaceuticals, Inc. 二羟苯基神经递质化合物、组合物以及方法
WO2015077520A1 (en) * 2013-11-22 2015-05-28 Auspex Pharmaceuticals, Inc. Methods of treating abnormal muscular activity
EP3424504A1 (en) 2013-12-03 2019-01-09 Auspex Pharmaceuticals, Inc. Methods of manufacturing benzoquinoline compounds
MX2016010213A (es) 2014-02-07 2017-04-13 Auspex Pharmaceuticals Inc Formulaciones farmaceuticas novedosas.
EP2918266A1 (en) 2014-03-11 2015-09-16 CDRD Berolina AB Composition comprising a dopamine agonist and an L-DOPA derivative for treating Parkinson's disease
GB201420341D0 (en) * 2014-11-17 2014-12-31 Evolution Valves Ltd Valve arrangement
CN114796209A (zh) 2015-03-06 2022-07-29 奥斯拜客斯制药有限公司 氘代丁苯那嗪或包含氘代丁苯那嗪的组合物
CN106343013A (zh) * 2015-07-19 2017-01-25 中国科学院上海有机化学研究所 一种粮食储存方法
CN105360267B (zh) * 2015-10-09 2017-11-10 青岛振坤食品机械有限公司 一种全自动穿串机
BR112018007118A2 (pt) 2015-10-09 2018-12-11 Teva Pharmaceuticals Int Gmbh método para tratar um distúrbio de deficiência de dopamina, método para melhorar o tempo motor ativo sem discinesia num paciente com doença de parkinson, método para reduzir discinesia num indivíduo com um distúrbio de deficiência de dopamina, método para reduzir o tempo motor inativo num indivíduo com um distúrbio de deficiência de dopamina, método para reduzir flutuações de nível de dopamina estriatal num indivíduo com um distúrbio de deficiência de dopamina, método para reduzir discinesia num indivíduo com um distúrbio de deficiência de dopamina após um tratamento de longo prazo, composição farmacêutica e embalagem
CN105862897B (zh) * 2016-04-11 2018-01-16 江苏省华建建设股份有限公司 砂质泥岩地基浅基础原槽浇筑施工工法
KR20210061355A (ko) 2018-09-13 2021-05-27 유니버시티 오브 캔버라 저해 방법
CA3121513A1 (en) * 2018-12-06 2020-06-11 Senda Biosciences, Inc. Decarboxylase inhibitors for treating parkinson's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699158A (en) 1969-08-25 1972-10-17 Merck & Co Inc Selective deuteration of tyrosine, aspartic and glutamic acids
DE2049807A1 (en) 1970-10-10 1972-04-13 Hartmeyer H Conversion of closed cell plastics foam to - open cell structure
DE2049115C3 (de) 1970-10-06 1981-07-30 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Tokyo Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa)
ATE76747T1 (de) * 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
IT1226902B (it) 1988-07-12 1991-02-21 Mini Ricerca Scient Tecnolog Processo per la sintesi del levodopa
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6440710B1 (en) * 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
EP1104760B1 (en) * 1999-12-03 2003-03-12 Pfizer Products Inc. Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
DE10261807A1 (de) * 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel
DE10261808A1 (de) 2002-12-19 2004-07-08 Turicum Drug Development Ag Verwendung von L-DOPA, seiner Derivate und diese Verbindungen enthaltender Arzneimittel zur Prophylaxe psychotischer Erkrankungen

Also Published As

Publication number Publication date
USRE46555E1 (en) 2017-09-19
LT1991522T (lt) 2016-09-26
UA97795C2 (uk) 2012-03-26
DK1991522T3 (en) 2016-08-29
ME02508B (me) 2017-06-20
IL193102A0 (en) 2009-02-11
CA2642593A1 (en) 2007-08-23
CN101384545A (zh) 2009-03-11
EP1991522B1 (en) 2016-05-18
CY1117995T1 (el) 2017-05-17
AU2007214622B2 (en) 2012-02-23
IL193102A (en) 2015-01-29
EA017983B1 (ru) 2013-04-30
PT1991522T (pt) 2016-08-23
JP5248331B2 (ja) 2013-07-31
WO2007093450A3 (en) 2007-09-27
AU2007214622A1 (en) 2007-08-23
HRP20161039T1 (hr) 2016-11-04
BRPI0708071A8 (pt) 2017-12-26
WO2007093450A2 (en) 2007-08-23
BRPI0708071A2 (pt) 2011-05-17
EP3101001A1 (en) 2016-12-07
HUE028777T2 (en) 2017-01-30
RS55142B1 (sr) 2016-12-30
SI1991522T1 (sl) 2016-10-28
EP1991522A2 (en) 2008-11-19
CA2642593C (en) 2014-11-04
KR20080106539A (ko) 2008-12-08
EP3101001B1 (en) 2020-04-01
PL1991522T3 (pl) 2017-07-31
US8247603B2 (en) 2012-08-21
EA200801826A1 (ru) 2009-02-27
ES2587368T3 (es) 2016-10-24
KR101411422B1 (ko) 2014-07-03
CN101384545B (zh) 2014-09-03
US20090018191A1 (en) 2009-01-15
JP2009526799A (ja) 2009-07-23

Similar Documents

Publication Publication Date Title
ZA200806568B (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
IL192565A0 (en) Medicament for topical use
GB0625659D0 (en) Therapeutic compounds and their use
IL194095A0 (en) Drug microparticles
IL202300A0 (en) 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative
IL194751A0 (en) Drugs and uses
ZA200809393B (en) Treatments using citrulline
IL196493A0 (en) Medication applicator device
IL197767A0 (en) Capecitabine pediatric tablets
EP2077262A4 (en) IMINOPYRIDINE DERIVATIVE AND USE THEREOF
IL195639A0 (en) Tricyclic compound and pharmaceutical use thereof
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
GB0614586D0 (en) Pharmaceutical Formulation
IL197883A0 (en) Combination drug
ZA201000187B (en) 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL199178A0 (en) Aminoalcohol derivatives and their therapeutic use
GB0625783D0 (en) Medicament
ZA201000186B (en) 17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative
EP2114404A4 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
GB0615064D0 (en) Medicament
GB0613031D0 (en) Medicaments
HK1124308A (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament